The most accurate and efficient monitoring device for heart rate variability

At the heart of innovation

icon-heart

What we do

After 23 years of research and development, Mdoloris Inc has released a heart rate variability monitoring device. The HFVI technology (High frequencies variability index) can be used in any operation room for any type of surgery. It can also be used in the PACU, ICU, during opioid free anesthesia (OFA) and hypnosis. Thanks to the algorithm, the HFVI monitor can help physicians evaluate the high frequency component of the heart rate variability in all types of patients, both unconscious or conscious.

How it works

HFVI CALCULATION PROCESS

icon-step-1

STEP 1

The calculation of our index relies on obtaining a series of R-R time intervals from the patient’s ECG signal.

icon-step-2

STEP 2

The resulting R-R series are filtered in real-time thanks to a detection algorithm. Each R-R series is then re-sampled, isolated in a temporary window and normalized.

icon-step-3

STEP 3

To finish the calculation we take all of the information extracted from the ECG and embed it into the algorithm for analysis.  That analysis allows for display of the indices and their curves..

Company

Mdoloris (www.mdoloris.com), a medical devices manufacturer, was created in June 2010 out of 23 years of academic research performed in Lille University hospital, France.
It has an international representation in more than 64 countries and a scientific, technical and medical acknowledgement.
Mdoloris has so far developed three products, all able to continuously assess the parasympathetic level of patients (the ANI technology for patients older than two years old, the NIPE technology for neonates, and the PTA technology for pets).
Its innovative technologies provide clinical added value for clinicians who are not able to communicate with their patients in order to personalize medications and avoid known side effects due to over- and under-dosage of such drugs.
More than 1,300 devices are now used by anesthesiologists and intensivists wordwide and more than 140,000 patients have benefited from Mdoloris’ technologies.
Mdoloris’s standalone monitor promoting its innovative adult technology has received 510(k) clearance through the HFVI brand in the US under the number K142969. Mdoloris recently closed a nine-million euro fundraising round in order to keep developing new-to-the-world technologies that always keep one target in mind: helping clinicians improve the quality of care.

world-map-site-us2x

icon-expertise-1

 

icon-expertise-2

 

icon-expertise-3

 

Contact us

For any questions, remarks or comments, please contact us via our contact form or by email.
We will get back to you as soon as possible.